Latest news
Loading news…
Astria Therapeutics develops therapies for allergic and immunologic diseases.
Astria Therapeutics was acquired by BioCryst Pharmaceuticals in 2025 for $700M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
77
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Cambridge, Massachusetts, United States
- Diversity spotlight
- Women Founded; Women Led
Acquisitions by Astria Therapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Astria Therapeutics
Chief Business Officer
Chief Scientific Officer
Chief Medical Officer
77
professional contacts at Astria Therapeutics
Contact execs at Astria Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Astria Therapeutics
Loading news…
FAQs about Astria Therapeutics
People who checked this page also checked these
Sectors Astria Therapeutics invests & acquires in
Browse the full Acquirezy directory.